Pancreatic cancer vaccine prevents HALF of patients' tumors returning

The German firm BioNTech has led research into the development of a new breakthrough vaccine for pancreatic cancer. It prevented the disease from returning in half of patients.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news